TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Performance of TB biomarker for targeted preventative therapy

An RNA signature of tuberculosis, RISK11, was used to discriminate between individuals with prevalent tuberculosis or progression to incident tuberculosis and individuals who remained healthy, according to a study in The Lancet Infectious Diseases.

Read the full story at Infectious Disease Advisor.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Bradley van Paridon

Published: May 6, 2021, 12:20 a.m.

Last updated: Nov. 14, 2024, 7:38 p.m.

Tags: Treatment

Print Share